Cost-Effectiveness of Antiobesity Medications for Adolescents With Severe Obesity
In adolescents with severe obesity, phentermine-topiramate is a cost-effective treatment at a willingness-to-pay threshold of $100,000 to $150,000 per quality-adjusted life-year (QALY), researchers report. “Further